0000921895-23-000702.txt : 20230316 0000921895-23-000702.hdr.sgml : 20230316 20230316180218 ACCESSION NUMBER: 0000921895-23-000702 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230314 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDRICK ALAN I CENTRAL INDEX KEY: 0001195340 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33957 FILM NUMBER: 23740079 MAIL ADDRESS: STREET 1: 20200 SUNBURST STREET CITY: CHATSWORTH STATE: CA ZIP: 91311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 4 1 form412799edr_03162023.xml OWNERSHIP DOCUMENT X0306 4 2023-03-14 0 0001123494 HARVARD BIOSCIENCE INC HBIO 0001195340 EDRICK ALAN I C/O HARVARD BIOSCIENCE, INC. 84 OCTOBER HILL RD. HOLLISTON MA 01746 1 0 0 0 Common Stock 2023-03-14 4 P 0 13808 2.67 A 186293 D Common Stock 2023-03-15 4 P 0 16192 2.62 A 202485 D This transaction was executed in multiple trades at prices ranging from $2.61 to $2.72, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $2.57 to $2.68, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Includes (a) 38,259 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2022, immediately prior to the commencement of such meeting, and (ii) May 24, 2023 and (b) 164,226 shares of common stock held by the Report Person. /s/ David Sirois, by power of attorney 2023-03-16